These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38024830)
1. Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution. Turbatu A; Dobrea C; Stoian M; Barta CT; Halcu G; Birceanu A; Bordea AM; Ghimici CG; Oprea MM; Neacșu LD; Lupu AR; Coliță A J Med Life; 2023 Aug; 16(8):1201-1210. PubMed ID: 38024830 [TBL] [Abstract][Full Text] [Related]
2. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes. Nagpal P; Descalzi-Montoya DB; Lodhi N Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852 [TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264 [TBL] [Abstract][Full Text] [Related]
4. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus. Zameer MA; Premalata CS; Arunakumari B; Appaji L; Rao CR Pediatr Hematol Oncol; 2015 May; 32(4):229-38. PubMed ID: 25252151 [TBL] [Abstract][Full Text] [Related]
5. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients. Antel K; Chetty D; Oosthuizen J; Mohamed Z; Van der Vyver L; Verburgh E Pathology; 2021 Aug; 53(5):628-634. PubMed ID: 33558066 [TBL] [Abstract][Full Text] [Related]
7. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group. Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W; Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566 [TBL] [Abstract][Full Text] [Related]
8. Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma. Adam M; Bekuretsion Y; Gebremedhin A; Kwiecinska A; Howe R; Petros B; Jerkeman M J Clin Exp Hematop; 2023; 63(4):230-239. PubMed ID: 38148013 [TBL] [Abstract][Full Text] [Related]
10. Lymphomagenesis in Hodgkin lymphoma. Matsuki E; Younes A Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205 [TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly. Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949 [TBL] [Abstract][Full Text] [Related]
12. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1. Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721 [TBL] [Abstract][Full Text] [Related]
13. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?]. Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676 [TBL] [Abstract][Full Text] [Related]
14. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma. Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma. Santisteban-Espejo A; Perez-Requena J; Atienza-Cuevas L; Moran-Sanchez J; Fernandez-Valle MDC; Bernal-Florindo I; Romero-Garcia R; Garcia-Rojo M Viruses; 2021 Dec; 13(12):. PubMed ID: 34960792 [TBL] [Abstract][Full Text] [Related]
16. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1. Cader FZ; Vockerodt M; Bose S; Nagy E; Brundler MA; Kearns P; Murray PG Blood; 2013 Dec; 122(26):4237-45. PubMed ID: 24136166 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment. Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884 [TBL] [Abstract][Full Text] [Related]
20. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]